DE3348322C2 - - Google Patents

Info

Publication number
DE3348322C2
DE3348322C2 DE3348322A DE3348322A DE3348322C2 DE 3348322 C2 DE3348322 C2 DE 3348322C2 DE 3348322 A DE3348322 A DE 3348322A DE 3348322 A DE3348322 A DE 3348322A DE 3348322 C2 DE3348322 C2 DE 3348322C2
Authority
DE
Germany
Prior art keywords
compound
acyl
diene
sulfone
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3348322A
Other languages
German (de)
English (en)
Inventor
Hector F. Deluca
Heinrich K. Madison Wis. Us Schnoes
Jacek W. Gif Sur Yvette Fr Morzycki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Application granted granted Critical
Publication of DE3348322C2 publication Critical patent/DE3348322C2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE3348322A 1982-09-20 1983-09-12 Expired - Lifetime DE3348322C2 (US07655746-20100202-C00011.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/420,191 US4448721A (en) 1982-09-20 1982-09-20 Hydroxyvitamin D2 compounds and process for preparing same

Publications (1)

Publication Number Publication Date
DE3348322C2 true DE3348322C2 (US07655746-20100202-C00011.png) 1991-07-25

Family

ID=23665448

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19833390212 Granted DE3390212T1 (de) 1982-09-20 1983-09-12 Hydroxyvitamin D↓2↓-Verbindungen und Verfahren zu deren Herstellung
DE3348322A Expired - Lifetime DE3348322C2 (US07655746-20100202-C00011.png) 1982-09-20 1983-09-12

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19833390212 Granted DE3390212T1 (de) 1982-09-20 1983-09-12 Hydroxyvitamin D↓2↓-Verbindungen und Verfahren zu deren Herstellung

Country Status (11)

Country Link
US (1) US4448721A (US07655746-20100202-C00011.png)
EP (1) EP0119251A1 (US07655746-20100202-C00011.png)
JP (6) JPS59501746A (US07655746-20100202-C00011.png)
CA (1) CA1283422C (US07655746-20100202-C00011.png)
CH (1) CH671222A5 (US07655746-20100202-C00011.png)
DE (2) DE3390212T1 (US07655746-20100202-C00011.png)
FR (3) FR2540869B1 (US07655746-20100202-C00011.png)
GB (2) GB2127023B (US07655746-20100202-C00011.png)
IE (1) IE56174B1 (US07655746-20100202-C00011.png)
IL (1) IL69763A (US07655746-20100202-C00011.png)
WO (1) WO1984001155A1 (US07655746-20100202-C00011.png)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5036061A (en) * 1983-05-09 1991-07-30 Deluca Hector F Process for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compounds
US4505906A (en) * 1984-01-30 1985-03-19 Wisconsin Alumni Research Foundation Hydroxyvitamin D2 isomers
US5120722A (en) * 1984-02-08 1992-06-09 Hoffmann-La Roche Inc. Trihydroxy-cholecacliferol and trihydroxy-ergocalciferol for treating leukemia
US4588716A (en) * 1984-05-04 1986-05-13 Wisconsin Alumni Research Foundation Method for treating metabolic bone disease in mammals
US4588528A (en) * 1984-05-31 1986-05-13 Wisconsin Alumni Research Foundation 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same
CH672920A5 (US07655746-20100202-C00011.png) * 1984-10-04 1990-01-15 Wisconsin Alumni Res Found
US4857518A (en) * 1984-10-04 1989-08-15 Wisconsin Alumni Research Foundation Hydroxylated 24-homo-vitamin D derivatives and methods for preparing same
US5225579A (en) * 1988-03-16 1993-07-06 Hoxan Corporation Method of manufacturing vitamin D2, Vitamin D3, activated type vitamin D2, activated type vitamin D3, and their derivatives
US5260290A (en) * 1990-02-14 1993-11-09 Wisconsin Alumni Research Foundation Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
US5030772A (en) * 1990-02-14 1991-07-09 Deluca Hector F Process for preparing vitamin D2 compounds and the corresponding 1 α-hydroxylated derivatives
IN171449B (US07655746-20100202-C00011.png) * 1990-02-14 1992-10-17 Wisconsin Alumni Res Found
US5063234A (en) * 1990-05-25 1991-11-05 Eli Lilly And Company Method of inhibiting demineralization of bone
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
ATE179604T1 (de) * 1991-01-08 1999-05-15 Bone Care Int Inc Verfahren zur herstellung und verwendung von 1alpha,24-dihydroxy vitamin-d2
CA2129120A1 (en) * 1992-01-29 1993-08-05 Joyce C. Knutson 1.alpha.-hydroxy-24-epi-vitamin d4
TW267161B (US07655746-20100202-C00011.png) * 1992-11-20 1996-01-01 Hoffmann La Roche
US5716946A (en) * 1996-02-13 1998-02-10 Wisconsin Alumni Research Foundation Multiple sclerosis treatment
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
WO2003029264A2 (en) * 2001-10-01 2003-04-10 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
US7094775B2 (en) * 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
US20060003950A1 (en) * 2004-06-30 2006-01-05 Bone Care International, Inc. Method of treating prostatic diseases using a combination of vitamin D analogues and other agents
US7947682B2 (en) * 2004-12-29 2011-05-24 University Of Southern California Substituted N′-pyrrolo[1,2-a]quinoxalin-4-yl-hydrazides as anti-cancer agents
DK1993559T3 (en) 2006-02-03 2016-10-03 Opko Renal Llc Treatment of vitamin D deficiency and MALFUNCTION with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
US8178509B2 (en) * 2006-02-10 2012-05-15 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) * 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
KR101495578B1 (ko) 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
DK2481400T3 (da) 2007-04-25 2014-09-29 Opko Ip Holdings Ii Inc Orale præparater med kontrolleret frigivelse omfattende en vitamin D-forbindelse og en voksagtig bærer
US8058259B2 (en) * 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists
ES2954932T3 (es) 2008-04-02 2023-11-27 Eirgen Pharma Ltd Métodos, composiciones, usos y kits útiles para la deficiencia de vitamina D y trastornos relacionados
EP2334640B1 (en) * 2008-07-22 2015-12-23 Azad Pharmaceutical Ingredients AG Methods for producing paricalcitol
MX339746B (es) 2009-01-27 2016-06-08 Berg Llc Vitamina d3 y análogos de la misma para aliviar efectos secundarios asociados con la quimioterapia.
JP5978130B2 (ja) 2009-08-14 2016-08-24 バーグ エルエルシー 脱毛症を治療するためのビタミンｄ３およびその類似体
CN105796530A (zh) 2010-03-29 2016-07-27 赛特克罗公司 用于降低甲状旁腺水平的方法和组合物
CA2698160C (en) * 2010-03-30 2017-07-25 Alphora Research Inc. Stabilized doxercalciferol and process for manufacturing the same
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
WO2014194133A1 (en) 2013-05-29 2014-12-04 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
IL290855B2 (en) 2016-03-28 2024-06-01 Eirgen Pharma Ltd Treatment methods using vitamin D
CN115947678B (zh) * 2023-03-10 2024-01-16 成都诺森医学检验有限公司 稳定同位素2h（d）标记25-羟基维生素d2的合成方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048698A1 (de) * 1980-12-23 1982-07-15 Wisconsin Alumni Research Foundation, 53707 Madison, Wis. Verfahren zur herstellung einer 1(alpha)-hydroxylierten vitamin-d-verbindung, ausgehend von einer 5,6-trans-vitamin-d-verbindung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2012069B1 (US07655746-20100202-C00011.png) * 1968-07-01 1973-06-08 Wisconsin Alumni Res Found
US3880894A (en) * 1974-05-24 1975-04-29 Wisconsin Alumni Res Found 1,25-Dihydroxyergocalciferol
US4105660A (en) * 1977-06-29 1978-08-08 Merck & Co., Inc. Preparation of 3β-hydroxy-27-norcholest-5,7-dien-25-one
US4145346A (en) * 1977-10-03 1979-03-20 Merck & Co., Inc. Preparation of 3β-hydroxy-27-norcholest-5-ene-25-one and intermediates thereof
US4188345A (en) * 1978-07-26 1980-02-12 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4229358A (en) * 1978-07-26 1980-10-21 Wisconsin Alumni Research Foundation Fluorovitamin D compounds and processes for their preparation
US4265822A (en) * 1979-09-10 1981-05-05 Wisconsin Alumni Research Foundation Process for preparing 1-hydroxylated vitamin D compounds from 5,6-trans-vitamin D compounds

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048698A1 (de) * 1980-12-23 1982-07-15 Wisconsin Alumni Research Foundation, 53707 Madison, Wis. Verfahren zur herstellung einer 1(alpha)-hydroxylierten vitamin-d-verbindung, ausgehend von einer 5,6-trans-vitamin-d-verbindung

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
C.A. 97, 216560h, 1982 *
C.A. 98, 16295q, 1983 *

Also Published As

Publication number Publication date
JPH02209864A (ja) 1990-08-21
FR2555172B1 (fr) 1987-08-07
EP0119251A1 (en) 1984-09-26
FR2555173A1 (fr) 1985-05-24
GB2142922B (en) 1986-08-28
DE3390212C2 (US07655746-20100202-C00011.png) 1991-10-31
GB2127023A (en) 1984-04-04
GB2142922A (en) 1985-01-30
IL69763A (en) 1987-01-30
CH671222A5 (US07655746-20100202-C00011.png) 1989-08-15
FR2555172A1 (fr) 1985-05-24
JPH02209863A (ja) 1990-08-21
US4448721A (en) 1984-05-15
GB2127023B (en) 1987-07-08
JPH0435458B2 (US07655746-20100202-C00011.png) 1992-06-11
JPH02209888A (ja) 1990-08-21
JPS59501746A (ja) 1984-10-18
CA1283422C (en) 1991-04-23
GB8325131D0 (en) 1983-10-19
FR2555173B1 (fr) 1989-04-07
JPH0518840B2 (US07655746-20100202-C00011.png) 1993-03-15
JPH0518839B2 (US07655746-20100202-C00011.png) 1993-03-15
JPH0443916B2 (US07655746-20100202-C00011.png) 1992-07-20
JPH0610187B2 (ja) 1994-02-09
FR2540869A1 (fr) 1984-08-17
DE3390212T1 (de) 1984-11-29
JPH0434540B2 (US07655746-20100202-C00011.png) 1992-06-08
IL69763A0 (en) 1983-12-30
JPH02209862A (ja) 1990-08-21
JPH02209887A (ja) 1990-08-21
IE832203L (en) 1984-03-20
IE56174B1 (en) 1991-05-08
WO1984001155A1 (en) 1984-03-29
FR2540869B1 (fr) 1988-04-15
GB8417477D0 (en) 1984-08-15

Similar Documents

Publication Publication Date Title
DE3348322C2 (US07655746-20100202-C00011.png)
DE2012167C2 (de) 25-Hydroxycholecalciferol-hydrat und Verfahren sowie Zwischenprodukte zu seiner Herstellung
DE69020605T2 (de) 1 alpha,25-Dihydroxyvitamin-D4-Verbindungen, Ergosta-5,7-dien-Verbindungen und Verfahren zu deren Herstellung.
CH653321A5 (de) 1alpha-hydroxylierte vitamin d-derivate und verfahren zu ihrer herstellung.
DE3590232C2 (de) 1,24-Dihydroxy- 22-Vitamin D3-Derivate, diese enthaltende Arzneimittel sowie Cholesterinderivate alsZwischenprodukte
CH641445A5 (de) Seitenketten-fluorierte vitamin d verbindungen.
DE3045287T1 (de) Isotopically labeled vitamin d derivatives and processes for preparing same
DE69109006T2 (de) HOMOLOGIERTE VITAMIN-D2-VERBINDUNGEN UND KORRESPONDIERENDE 1alpha-HYDROXYLIERTE VERBINDUNGEN.
DE3448360C2 (US07655746-20100202-C00011.png)
DE3490636C2 (de) Hydroxyvitamin D¶2¶-Isomere, Zwischenprodukt zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0572489B1 (de) Ausgangsverbindungen zur herstellung von calcitriol sowie dessen abkömmlingen, verfahren zur herstellung dieser ausgangsverbindungen sowie zwischenprodukte für dieses verfahren
DE69005709T2 (de) Adduktaldehyd und seine Anwendung in der Herstellung von Vitamin-D-Derivaten.
DE3590488C2 (US07655746-20100202-C00011.png)
DE2326008A1 (de) Verfahren zur herstellung von 25hydroxycholesterin und deren ester
DE69318142T2 (de) 1 alpha-HYDROXY-24-(EPI)-VITAMIN D4
DE2812741C2 (de) Vitamin D↓3↓-Derivate, Verfahren und Zwischenprodukte zu deren Herstellung und diese enthaltende Arzneimittel
DE69108319T2 (de) Verfahren zur herstellung von vitamin-d2-verbindungen und ihrer 1-alpha hydrogenierten derivate.
DE69327050T2 (de) Reinigung von 5-7-dien-steroiden von einem steringemisch
CH635826A5 (de) Vitamin d(3)-derivate.
DE3590020C2 (de) In der Seitenkette ungesättigte 1-Hydroxyvitamin D-Verbindungen
JP2818494B2 (ja) ビタミンＤ２ 化合物及び対応の１α−ヒドロキシル化誘導体の製造方法
CH667658A5 (de) 1-alpha-hydroxyvitamin d2-analogverbindungen.
DE69406183T2 (de) Jodvitamin-D-Verbindungen und Verfahren zu ihrer Herstellung
DE68915541T2 (de) Herstellung von vitamin d2 und vitamin d3 oder aktivem vitamin d2 und aktivem vitamin d3 oder ihren derivaten.
DE3048698A1 (de) Verfahren zur herstellung einer 1(alpha)-hydroxylierten vitamin-d-verbindung, ausgehend von einer 5,6-trans-vitamin-d-verbindung

Legal Events

Date Code Title Description
8172 Supplementary division/partition in:

Ref country code: DE

Ref document number: 3390212

Format of ref document f/p: P

Q171 Divided out to:

Ref country code: DE

Ref document number: 3390212

8110 Request for examination paragraph 44
8181 Inventor (new situation)

Free format text: DELUCA, HECTOR F. SCHNOES, HEINRICH K., MADISON, WIS., US MORZYCKI, JACEK W., GIF SUR YVETTE, FR

AH Division in

Ref country code: DE

Ref document number: 3390212

Format of ref document f/p: P

D2 Grant after examination
AH Division in

Ref country code: DE

Ref document number: 3390212

Format of ref document f/p: P

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee